Home

telt hertuginne Presse ned constant ratio drug design nature 2016 Ha råd til Ordliste ordbok

Synthetic prodrug design enables biocatalytic activation in mice to elicit  tumor growth suppression | Nature Communications
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression | Nature Communications

A rational blueprint for the design of chemically-controlled protein  switches | Nature Communications
A rational blueprint for the design of chemically-controlled protein switches | Nature Communications

Engineering precision nanoparticles for drug delivery | Nature Reviews Drug  Discovery
Engineering precision nanoparticles for drug delivery | Nature Reviews Drug Discovery

Coronaviruses — drug discovery and therapeutic options | Nature Reviews Drug  Discovery
Coronaviruses — drug discovery and therapeutic options | Nature Reviews Drug Discovery

Strategies and challenges for the next generation of antibody–drug  conjugates | Nature Reviews Drug Discovery
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery

Designing hydrogels for controlled drug delivery | Nature Reviews Materials
Designing hydrogels for controlled drug delivery | Nature Reviews Materials

Design of protein-binding proteins from the target structure alone | Nature
Design of protein-binding proteins from the target structure alone | Nature

Pharmacophore hybridisation and nanoscale assembly to discover  self-delivering lysosomotropic new-chemical entities for cancer therapy |  Nature Communications
Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy | Nature Communications

Counting on natural products for drug design | Nature Chemistry
Counting on natural products for drug design | Nature Chemistry

Exploring protein hotspots by optimized fragment pharmacophores | Nature  Communications
Exploring protein hotspots by optimized fragment pharmacophores | Nature Communications

Network-based approach to prediction and population-based validation of in  silico drug repurposing | Nature Communications
Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications

A unified drug–target interaction prediction framework based on knowledge  graph and recommendation system | Nature Communications
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications

New strategy for drug discovery by large-scale association analysis of  molecular networks of different species | Scientific Reports
New strategy for drug discovery by large-scale association analysis of molecular networks of different species | Scientific Reports

A combined high-throughput and high-content platform for unified on-chip  synthesis, characterization and biological screening | Nature Communications
A combined high-throughput and high-content platform for unified on-chip synthesis, characterization and biological screening | Nature Communications

Bioorthogonal in situ assembly of nanomedicines as drug depots for  extracellular drug delivery | Nature Communications
Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery | Nature Communications

Improving Drug Candidates by Design: A Focus on Physicochemical Properties  As a Means of Improving Compound Disposition and Safety | Chemical Research  in Toxicology
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety | Chemical Research in Toxicology

Machine learning models to accelerate the design of polymeric long-acting  injectables | Nature Communications
Machine learning models to accelerate the design of polymeric long-acting injectables | Nature Communications

A machine learning-based chemoproteomic approach to identify drug targets  and binding sites in complex proteomes | Nature Communications
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications

A genome-wide positioning systems network algorithm for in silico drug  repurposing | Nature Communications
A genome-wide positioning systems network algorithm for in silico drug repurposing | Nature Communications

The emerging role of mass spectrometry-based proteomics in drug discovery |  Nature Reviews Drug Discovery
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery

Massively parallel de novo protein design for targeted therapeutics | Nature
Massively parallel de novo protein design for targeted therapeutics | Nature

Predictive validity in drug discovery: what it is, why it matters and how  to improve it | Nature Reviews Drug Discovery
Predictive validity in drug discovery: what it is, why it matters and how to improve it | Nature Reviews Drug Discovery

Using human genetics to improve safety assessment of therapeutics | Nature  Reviews Drug Discovery
Using human genetics to improve safety assessment of therapeutics | Nature Reviews Drug Discovery

The expanding role for small molecules in immuno-oncology | Nature Reviews Drug  Discovery
The expanding role for small molecules in immuno-oncology | Nature Reviews Drug Discovery

Late-stage C–H functionalization offers new opportunities in drug discovery  | Nature Reviews Chemistry
Late-stage C–H functionalization offers new opportunities in drug discovery | Nature Reviews Chemistry

The implications of target saturation for the use of drug–target residence  time | Nature Reviews Drug Discovery
The implications of target saturation for the use of drug–target residence time | Nature Reviews Drug Discovery